Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 22 Breast Neoplasms 21 Polycystic Ovary Syndrome 12 Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 10 Lung Neoplasms 8 Endometrial Neoplasms 7 Pancreatic Neoplasms 6 Neoplasms 6 Glioblastoma 5 Rectal Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Insulin Resistance 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Uterine Cervical Neoplasms 3 Leukoplakia, Oral 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Obesity 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Endometrial Hyperplasia 2 Diabetes Mellitus 2 Colonic Neoplasms 2

Interventions

Ifosfamide 15 Methotrexate 12 Doxorubicin 12 Filgrastim 10 Cisplatin 10 Cyclophosphamide 9 Etoposide 8 Gemcitabine 7 cabozantinib 6 apatinib 6 Magnetic Resonance Spectroscopy 6 Leucovorin 6 X-Rays 5 Specimen Handling 5 Sirolimus 5 Phantoms, Imaging 5 Nivolumab 5 Neoadjuvant Therapy 5 camrelizumab 4 Vincristine 4 Topotecan 4 Radiotherapy 4 Nuclear Medicine Department, Hospital 4 Drug Therapy 4 Docetaxel 4 Biopsy 4 regorafenib 3 palbociclib 3 olaparib 3 mifamurtide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Osteosarcoma × Metformin × Clear all

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡